Jennifer A. Doudna Sells 625 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) Director Jennifer A. Doudna sold 625 shares of the firm's stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $62.52, for a total value of $39,075.00. Following the completion of the transaction, the director owned 26,554 shares of the company's stock, valued at approximately $1,660,156.08. This represents a 2.30% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tempus AI Trading Up 2.5%

Shares of Tempus AI stock traded up $1.47 during trading on Friday, reaching $60.65. The company's stock had a trading volume of 6,389,112 shares, compared to its average volume of 7,393,926. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a 52-week low of $30.77 and a 52-week high of $91.45. The firm's 50-day moving average is $62.37 and its two-hundred day moving average is $53.83. The company has a market cap of $10.50 billion and a price-to-earnings ratio of -7.78.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. Tempus AI's revenue was up 75.4% on a year-over-year basis. On average, sell-side analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.

Institutional Investors Weigh In On Tempus AI

Large investors have recently modified their holdings of the stock. ARK Investment Management LLC boosted its position in shares of Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after purchasing an additional 1,981,755 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after buying an additional 5,900,668 shares in the last quarter. Nikko Asset Management Americas Inc. boosted its holdings in shares of Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after buying an additional 1,021,460 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in shares of Tempus AI by 31.4% in the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock worth $205,284,000 after buying an additional 1,016,384 shares during the period. Finally, Franklin Resources Inc. increased its stake in shares of Tempus AI by 240.5% in the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock worth $93,251,000 after acquiring an additional 1,950,862 shares in the last quarter. Institutional investors own 24.22% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently commented on the company. BTIG Research started coverage on Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 target price for the company. Morgan Stanley boosted their price objective on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Bank of America raised their target price on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC reissued a "buy" rating and issued a $70.00 price target on shares of Tempus AI in a research note on Wednesday, May 7th. Finally, Piper Sandler increased their price target on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $63.67.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.